News

Philip Morris International Inc. announced it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative…
Read More...

Seres Therapeutics, Inc. announced that it has entered into an agreement with Nestlé Health Science to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic…
Read More...

Following approval from the United States Bankruptcy Court for the District of Delaware, Mandos, LLC (Mandos) announced it has closed the acquisition of Adrabetadex (also known as…
Read More...

Bioasis Technologies Inc. and Oxyrane UK Ltd. are pleased to announce the initiation of a research collaboration. Bioasis is a pre-clinical, research-stage biopharmaceutical company…
Read More...

Apellis Pharmaceuticals, Inc. and Beam Therapeutics Inc. announced an exclusive five-year research collaboration focused on the use of Beam’s proprietary base editing technology to…
Read More...

OnCusp Therapeutics a global biopharmaceutical company focused on translating cutting-edge research assets into innovative oncology therapeutics, announced that it has officially…
Read More...

Gavi, the Vaccine Alliance announced that it had signed an advance purchase agreement (APA) with Clover Biopharmaceuticals for its SCB-2019 protein-based adjuvanted vaccine candidate…
Read More...

Altimmune, Inc. a clinical-stage biopharmaceutical company, today provided an update on its AdCOVID investigational vaccine for the prevention of COVID-19. The Company also provided an…
Read More...

FUJIFILM Corporation announced a ¥90 Billion Yen (~$850 Million USD) investment package to accelerate the growth of its core Bio CDMO subsidiary, FUJIFILM Diosynth Biotechnologies.…
Read More...

Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery…
Read More...

Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, received a positive opinion…
Read More...

RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced preliminary results of a new preclinical study showing potent inhibition of COVID-19 variants of concern by…
Read More...

Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate the development and delivery of…
Read More...

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced that the U.S. Food & Drug Administration (FDA) has granted…
Read More...

Frontage Holdings Corporation announced that its wholly-owned subsidiary, Frontage Laboratories, Inc. has entered into a definitive agreement for the acquisition of Quintara Discovery,…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune…
Read More...

AbbVie announced new data on upadacitinib (RINVOQ) in ulcerative colitis and risankizumab (SKYRIZI) in Crohn's disease will be presented as oral presentations at the 16th Congress of…
Read More...

LFB Plasma (www.lfbplasma.com) announced today the acquisition of the ImmunoTek Bio Center located at 4560 Lake Worth Road, Greenacres, FL 33463. LFB Plasma is part of the LFB Group, a…
Read More...

Captivate Bio, a scientific cell culture solutions provider, announced it has signed an exclusive distribution agreement with PL BioScience GmbH, a biotech company located in Aachen,…
Read More...

As part of Sanofi’s ongoing efforts to reduce the complexity of its Consumer Healthcare portfolio and accelerate its growth trajectory, the company has signed an agreement with STADA…
Read More...